IL-1β is a key cytokine implicated in the development of different chronic inflammatory diseases and, therefore, P2X7 receptor is a potential target to develop anti-inflammatory drugs to treat chronic inflammatory conditions as rheumatoid arthritis or Crohn’s disease (5–7). Here, P2RX7 is linked to Crohn disease.